Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 29, Issue 2, Pages 776-785
Publisher
Springer Nature
Online
2011-02-19
DOI
10.1007/s12032-011-9855-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim results of a phase II trial of pemetrexed and oxaliplatin as 2nd/3rd line therapy in hormone refractory prostate cancer
- (2017) T. B. Dorff et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
- (2010) Tomasz M. Beer et al. ANTI-CANCER DRUGS
- Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
- (2010) Jean-Christophe Eymard et al. BJU INTERNATIONAL
- The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer
- (2010) Yohann Loriot et al. EUROPEAN JOURNAL OF CANCER
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
- (2010) Daniel C. Danila et al. JOURNAL OF CLINICAL ONCOLOGY
- METRONOMIC CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH ADVANCED, CASTRATION-RESISTANT PROSTATE CANCER
- (2010) Andrea Fontana et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
- (2010) A J Armstrong et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer
- (2010) Christoph W. M. Reuter et al. WORLD JOURNAL OF UROLOGY
- A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
- (2009) N. M. Hahn et al. ANNALS OF ONCOLOGY
- Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
- (2009) Y. Loriot et al. ANNALS OF ONCOLOGY
- Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
- (2009) A. Fontana et al. CLINICAL CANCER RESEARCH
- Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
- (2009) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Novel secondary hormonal therapy in advanced prostate cancer: an update
- (2009) Eliezer M Van Allen et al. CURRENT OPINION IN UROLOGY
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy
- (2009) Thomas Nelius et al. MEDICAL ONCOLOGY
- Paclitaxel, Estramustine and Carboplatin Combination Chemotherapy after Initial Docetaxel-Based Chemotherapy in Castration-Resistant Prostate Cancer
- (2009) A. Sella et al. ONCOLOGY
- Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
- (2009) Elahe A. Mostaghel et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer
- (2008) A. Hussain et al. ANNALS OF ONCOLOGY
- Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer
- (2008) Mari Nakabayashi et al. BJU INTERNATIONAL
- A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
- (2008) J Shamash et al. BRITISH JOURNAL OF CANCER
- Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
- (2008) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
- (2008) Helmut Bonkhoff et al. EUROPEAN UROLOGY
- Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone
- (2008) Orazio Caffo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Biweekly Doxorubicin/Ketoconazole as Second-Line Treatment in Docetaxel-Resistant, Hormone-Refractory Prostate Cancer
- (2008) George Lainakis et al. UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started